Related Experiment Videos
Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' reply
Rasha El Sharkawy1, Jacob George1, Mohammed Eslam1
1Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.
Alimentary Pharmacology & Therapeutics
|September 25, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations.
Expert review of endocrinology & metabolism·2026
The coexistence of MAFLD increases fibrosis burden in patients with chronic hepatitis B.
Scientific reports·2026
Current and Future Landscape of Hepatocellular Carcinoma Treatment.
Oncology research·2026
Health inequity and the risk of MAFLD/MASLD.
Clinical nutrition ESPEN·2026
Multi-omics uncovers the pleiotropic genetic mechanisms linking MASLD and cardiometabolic syndromes.
Cardiovascular diabetology·2026
Bowel Preparation in Quality Guidelines and Clinical Practice.
Alimentary pharmacology & therapeutics·2026
Modern Bowel Preparations, Clinical Evidence and Practical Advantages.
Alimentary pharmacology & therapeutics·2026
The Clinical Importance of Adequate Bowel Preparation.
Alimentary pharmacology & therapeutics·2026
Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis.
Alimentary pharmacology & therapeutics·2026
Neighbourhood Deprivation Is Associated With Greater Mortality in Patients With Alcohol-Associated Liver Disease.
Alimentary pharmacology & therapeutics·2026
Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Journal of thrombosis and thrombolysis·2026